Patents by Inventor Brooke Anderson

Brooke Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240002851
    Abstract: The present disclosure provides oligomeric compounds (including oligomeric compounds that are antisense agents or portions thereof) comprising a modified oligonucleotide having at least one modified internucleoside linking group.
    Type: Application
    Filed: January 25, 2023
    Publication date: January 4, 2024
    Applicant: Ionis Pharmaceuticals, Inc.
    Inventors: Brooke A. Anderson, Xue-Hai Liang, William John Drury, III, Michael Oestergaard, Michael T. Migawa, Punit P. Seth
  • Publication number: 20230263962
    Abstract: Apparatus and method for syringe support are disclosed. The syringe-support apparatus may include a front arm and a back arm connected at a hinge mechanism. The front and back arms may comprise a finger grip and thumb grip. A user may employ a well-known scissor-like movement in view of the finger grip and thumb grip, combined with the hinge mechanism. The front and back arms may further comprise a syringe securing mechanism, which may correlate hand motion with a syringe plunger motion. In view of the finger grip, thumb grip, and syringe securing mechanism, respectively, a user may engage the user's forearm muscles during aspiration and injection. The securing mechanism may comprise an adjustable barrel support and barrel support hook to secure a syringe barrel.
    Type: Application
    Filed: November 18, 2020
    Publication date: August 24, 2023
    Inventors: David F DALURY, Brooke ANDERSON
  • Patent number: 11629348
    Abstract: The present disclosure provides oligomeric compounds (including oligomeric compounds that are antisense agents or portions thereof) comprising a modified oligonucleotide having at least one modified internucleoside linking group.
    Type: Grant
    Filed: February 15, 2022
    Date of Patent: April 18, 2023
    Assignee: Ionis Pharmaceuticals, Inc.
    Inventors: Brooke A. Anderson, Xue-hai Liang, William John Drury, III, Michael Oestergaard, Michael T. Migawa, Punit P. Seth
  • Publication number: 20220186222
    Abstract: The present disclosure provides oligomeric compounds (including oligomeric compounds that are antisense agents or portions thereof) comprising a modified oligonucleotide having at least one modified internucleoside linking group.
    Type: Application
    Filed: February 15, 2022
    Publication date: June 16, 2022
    Applicant: Ionis Pharmaceuticals, Inc.
    Inventors: Brooke A. Anderson, Xue-hai Liang, William John Drury, III, Michael Oestergaard, Michael T. Migawa, Punit P. Seth
  • Publication number: 20060041936
    Abstract: A graphical representation of the firewall and a network coupled to the firewall is generated and displayed. A number of an inbound port of the network is displayed. An arrow adjacent to the port number pointing toward the network is displayed to indicate that a communication is permitted to the port. The port number and the arrow are located between an icon for the network and an icon for the firewall. A port number of a destination of a communication originating from the network is displayed. Also, another arrow adjacent to the destination port number pointing toward the firewall is displayed to indicate that a communication is permitted to the destination port number. The destination port number and the other arrow are located between an icon for the network and an icon for the firewall. A table including definitions of a plurality of rules is generated and displayed. Each of the definitions includes entries for a source IP address and destination IP address of a permitted but vulnerable data flow.
    Type: Application
    Filed: August 19, 2004
    Publication date: February 23, 2006
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Brooke Anderson, William Bunn, Mary Karnes, Sarah Lieberman, Mira Wilczek
  • Publication number: 20030040870
    Abstract: There is disclosed an automated system and process for providing a fully automated process for the design, manufacture and analysis of data for biological array (“biochip”) devices. Specifically, there is further disclosed a process and system for obtaining customer orders for custom-designed biochips comprising obtaining desired target sequences from the customer, wherein the target sequences consist essentially of oligonucleotide sequences, polypeptide sequences, or antigens to be bound; creating a sequence content motif for an array, wherein the sequence content motif consists essentially of oligonucleotide sequences, polypeptide sequences, or binding agents designed for complimentary binding; and applying the content motif to a surface suitable for later detection.
    Type: Application
    Filed: April 18, 2001
    Publication date: February 27, 2003
    Inventors: Brooke Anderson, Siavash Ghazvini, Patrick Quarles
  • Patent number: 5089338
    Abstract: A label with a polypropylene core is provided with an extruded skin of polypropylene bonded to each face of the core, and opaquing agent layer bonded to one extruded polypropylene skin to provide opacity to block out preprinted graphics or printing on the object to which the label is secured, pressure sensitive aqueous acrylic polymer emulsion adhesive bonded to the opaquing agent layer for securing the label to any object, and printing or graphics bonded to the face of the other extruded polypropylene skin, and a clear polypropylene skin with pressure sensitive aquaous acrylic polymer emulsion adhesive bonded to the graphics or printing to protect the graphics or printing.
    Type: Grant
    Filed: September 17, 1990
    Date of Patent: February 18, 1992
    Assignee: Salem Label Company, Inc.
    Inventors: Brooke Anderson, John W. Smith